Month: May 2018

First patient at the Istituto Nazionale dei Tumori hospital in Milan, Italy

On May 22th 2018, the first patient at the Istituto Nazionale dei Tumori was treated with QuiremSpheres®. The team, led by Prof. Dr. Mazzaferro (surgeon), Dr. Bhoori (hepatologist), Dr. Maccauro (nuclear medicine), Dr. Carlo Spreafico (Interventional Radiology) and Dr. Chieza (medical physics) used QuiremSpheres® for treatment of a patient suffering from

Read More »

A new milestone in the collaboration between RTM and Quirem Medical

As of the 22nd of May 2018, the Radboud Translational Medicine (RTM) is fully operational for performing the final steps in the manufacturing process of QuiremSpheres®. The RTM offers state-of-the-art facilities for the production and processing of radioactive pharmaceuticals and medical devices. Jan Sigger, CEO of Quirem Medical, comments: “It

Read More »

Meet us at WCIO 2018 in Boston!

The Quirem Medical team will be present at the WCIO Annual Meeting in Boston, Massachusetts from 7 – 10 of June, 2018. In case you are interested in meeting the team or want to find out more about QuiremSpheres®, we suggest that you use the contact form on our website

Read More »

Meet us at SNMMI 2018 in Philadelphia

The Quirem Medical team will be present at the SNMMI Annual Meeting in Philadelphia from 23-26 June 2018. In case you are interested in meeting the team or want to find out more about QuiremSpheres®, we suggest that you use the contact form on our website or send an e-mail

Read More »

First patient treated with QuiremSpheres® at the Florence Nightingale hospital in Turkey

On May 4th 2018, the first patient in Turkey was treated with QuiremSpheres® at the Florence Nightingale Hospital in Istanbul. Prof. Dr. Murat Cantaşdemir and Dr. Abdullah Yakupoğlu, both interventional radiologists, together with nuclear physician Prof. Dr. Cüneyt Türkmen, successfully performed the radioembolization procedure with QuiremSpheres® (holmium-based microspheres). The patient

Read More »